
    
      To establish the correlation between measurand values as obtained from the Samsung LABGEO
      PT10 Hepatic Panel at the point of care, and the corresponding measurand values as obtained
      on a commercial clinical chemistry analyzer, with respect to prospectively collected human
      serum specimens.
    
  